NDUFA9 Polyclonal Antibody

货号：ES6343
价格：面议
点击：2358

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human;Mouse;Rat
别称	NDUFA9; NDUFS2L; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9; mitochondrial; Complex I-39kD; CI-39kD; NADH-ubiquinone oxidoreductase 39 kDa subunit

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	450
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	425
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	398
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	425
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|程度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	722
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|抗度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	653
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	480
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	521
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	463
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	451
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	511
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	464
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	450
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	492
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	653
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	446
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	399
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	377
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	384
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	369

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00